Cefuroxime Sodium/Tazobactam Sodium

头孢呋辛钠/他唑巴坦钠

Report date: 2026/05/26 20:00:28

Base Information

Drug NameCefuroxime Sodium/Tazobactam Sodium
Drug Alias Name注射用头孢呋辛钠他唑巴坦钠(2:1)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitorsBeta Lactamase inhibitors
TargetsBacterial penicillin-binding proteinBeta Lactamase
Therapy Area/IndicationsBacterial InfectionsInfections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Cefuroxime SodiumTazobactam Sodium
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsBacterial InfectionsInfections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A